240 related articles for article (PubMed ID: 37396847)
1. An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI).
Murillo LC; Sutachan JJ; Albarracín SL
Toxicol Rep; 2023; 10():544-553. PubMed ID: 37396847
[TBL] [Abstract][Full Text] [Related]
2. The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".
Gaman AM; Uzoni A; Popa-Wagner A; Andrei A; Petcu EB
Aging Dis; 2016 May; 7(3):307-17. PubMed ID: 27330845
[TBL] [Abstract][Full Text] [Related]
3. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment.
Lal R; Dharavath RN; Chopra K
Mol Neurobiol; 2024 Feb; 61(2):593-608. PubMed ID: 37644279
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
7. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models - A systematic review.
Haller OJ; Semendric I; George RP; Collins-Praino LE; Whittaker AL
Neurosci Biobehav Rev; 2023 May; 148():105120. PubMed ID: 36906244
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.
Mounier NM; Abdel-Maged AE; Wahdan SA; Gad AM; Azab SS
Life Sci; 2020 Oct; 258():118071. PubMed ID: 32673664
[TBL] [Abstract][Full Text] [Related]
10. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment.
Boullon L; Abalo R; Llorente-Berzal Á
Front Pharmacol; 2021; 12():734613. PubMed ID: 34867342
[TBL] [Abstract][Full Text] [Related]
12. Quantifying chemotherapy-induced cognitive impairment in gastrointestinal cancer patients: A scoping review of methodological concerns in the literature.
Lau J; Khoo AM; Choe L; Hoon A; Tan KK
Asia Pac J Clin Oncol; 2024 May; ():. PubMed ID: 38808735
[TBL] [Abstract][Full Text] [Related]
13. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
14. Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real.
Argyriou AA; Assimakopoulos K; Iconomou G; Giannakopoulou F; Kalofonos HP
J Pain Symptom Manage; 2011 Jan; 41(1):126-39. PubMed ID: 20832978
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.
Rummel NG; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Cell Mol Life Sci; 2021 Oct; 78(19-20):6533-6540. PubMed ID: 34424346
[TBL] [Abstract][Full Text] [Related]
16. Chemobrain: An accelerated aging process linking adenosine A
Oliveros A; Poleschuk M; Cole PD; Boison D; Jang MH
Int Rev Neurobiol; 2023; 170():267-305. PubMed ID: 37741694
[TBL] [Abstract][Full Text] [Related]
17. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
18. Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen.
Liu S; Ni J; Yan F; Yin N; Li X; Ma R; Wu J; Zhou G; Feng J
Front Oncol; 2022; 12():1027515. PubMed ID: 36408140
[TBL] [Abstract][Full Text] [Related]
19. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced cognitive impairment from the forensic medicine perspective: A review of the updated literature.
Turrina S; Gibelli F; De Leo D
J Forensic Leg Med; 2020 Nov; 76():102070. PubMed ID: 33099125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
